Myristoyl lysophosphatidylcholine is a biomarker and potential therapeutic target for community-acquired pneumonia-Reference-Cited by-同舟云学术

Myristoyl lysophosphatidylcholine is a biomarker and potential therapeutic target for community-acquired pneumonia

Published:2022-12 Issue: Volume:58 Page:102556
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Nan Wengang,Xiong Fen,Zheng Hong,Li Chen,Lou Cong,Lei Xiong,Wu Huizhen,Gao Hongchang,Li Yuping

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference44 articles.

1. Biomarkers and community-acquired pneumonia: tailoring management with biological data[C]//Seminars in respiratory and critical care medicine;Torres;Thieme Med. Publish,2012

2. Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia[J];Christ-Crain;Crit. Care,2010

3. Diagnosis and treatment of community‐acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association[J];Cao;clinic. respir. J.,2018

4. Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis[J];Aliberti;Respir. Res.,2014

5. Prevalence and etiology of community-acquired pneumonia in immunocompromised patients[J];Di Pasquale;Clin. Infect. Dis.,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3-methyladenine ameliorates acute lung injury by inhibiting oxidative damage and apoptosis;Heliyon;2024-07

2. Comparative analysis of lysophospholipid metabolism profiles and clinical characteristics in patients with high vs. low C-reactive protein levels in acute exacerbations of chronic obstructive pulmonary disease;Clinica Chimica Acta;2024-07

3. The Role of Lysophospholipid Metabolites LPC and LPA in the Pathogenesis of Chronic Obstructive Pulmonary Disease;Metabolites;2024-05-31

4. Lipidome is a valuable tool for the severity prediction of coronavirus disease 2019;Frontiers in Immunology;2024-05-10

5. Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia;Metabolomics;2024-03-05